Recent News

• OpGen Announces Pricing of $10.0 Million Public Offering
  07-13-2017
• OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health
  07-12-2017
• OpGen Signs Supply Agreement to Use Thermo Fisher Scientific’s Technology to Advance Acuitas® Rapid Test
  06-19-2017
• OpGen’s Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities
  06-15-2017

Read More RSS Feed

Rapid Antibiotic Resistance Surveillance

Learn More

CONNECT WITH OpGen

We want to add you to our list and stay connected.

Please sign up for email alerts to receive the latest OpGen news.

Sign up for email alerts

Microbial Whole Genome Sequencing

Learn More

Webinars

Now Available On Demand

Esther Babady, Ph.D

Director of Clinical Microbiology Operations, Memorial Sloan Kettering Cancer Center

This webinar will review current options for rapid pathogen identification from positive blood cultures and discuss the speaker’s experience with the use of AdvanDx QuickFISH^® BC kits and their impact on the laboratory workflow and patient outcomes.

Learn More

OpGen Helps District of Columbia Hospitals Combat CRE

Rapid Pathogen Identification

Learn More